Join
Live feed
·
INSIDERFilingvia Quantisnow
CRISPR Therapeutics AG logo

Chief Operating Officer Bruno Julianne converted options into 3,750 shares and sold $70,668 worth of shares (1,714 units at $41.23), increasing direct ownership by 24% to 10,544 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRSP (CRISPR Therapeutics AG) and more on Quantisnow.

Chief Operating Officer Bruno Julianne converted options into 3,750 shares and sold $70,668 worth of shares (1,714 units at $41.23), increasing direct ownership by 24% to 10,544 units (SEC Form 4) | Quantisnow